Lung Cancer

lung cancer nodes :: Article Creator Lung Disease News Aug. 11, 2023 — Yoga and breathing control practices, in combination with aerobic training, are particularly key exercises for asthmatic people seeking to improve their lung function, a new peer-reviewed study ... Aug. 9, 2023 — New findings may lead to relapse-free treatment for a sizeable subgroup of lung cancer patients. In a study in mice, scientists have identified a biomarker that may help physicians select lung cancer ... Aug. 8, 2023 — Overly active immune cells are often behind lung damage in diseases such as Covid-19. Researchers have developed an RNA agent for a lung spray that slows the activity of these cells, known as ... July 25, 2023 — Having a food allergy as a baby is linked to asthma and reduced lung function later in childhood, according to a new ... July 20, 2023 — Omega-3 fatty acids, which are abundant in fish and fish oil supplements, appear promising fo...

stage 4 renal cell carcinoma :: Article Creator Bristol Myers' Injectable Kidney Cancer Drug Found Non-inferior To IV Form (Reuters) – Bristol Myers Squibb said on Thursday its injectable form of blockbuster cancer drug Opdivo was found to be non-inferior to the approved intravenous form in a late-stage trial for treatment of a type of kidney cancer. (This story has been refiled to fix a typo in the headline) (Reporting by Leroy Leo in Bengaluru; Editing by Anil D'Silva) Bristol Myers Squibb's Subcutaneous Opdivo Shows Promise In Kidney Cancer Trial Bristol Myers Squibb (BMS) has shared positive results from a late-stage study of a new injectable form of Opdivo (nivolumab) in certain kidney cancer patients. The phase 3 CheckMate-67T trial has been evaluating subcutaneous Opdivo, co-formulated with Halozyme's proprietary recombinant human hyaluronidase technology, compared to the drug's intravenous form in patien...

stage ib lung cancer adjuvant chemotherapy :: Article Creator Lung Cancer Outcomes Significantly Improved With Immunotherapy-based Treatment Given Before And After Surgery A regimen of pre-surgical immunotherapy and chemotherapy followed by post-surgical immunotherapy significantly improved event-free survival (EFS) and pathologic complete response (pCR) rates compared to chemotherapy alone for patients with operable non-small cell lung cancer (NSCLC), according to results of a Phase III trial reported by researchers at The University of Texas MD Anderson Cancer Center. The findings, published today in the New England Journal of Medicine, were first presented at the American Association for Cancer Research (AACR) Annual Meeting 2023. The AEGEAN trial evaluated durvalumab given perioperatively, meaning therapy is given both before and after surgery. Participants on the trial received either pre-surgical (neoadjuvant) durvalumab and platinum-based c...

nsclc prognosis by stage :: Article Creator Alectinib Reduces Risk Of Recurrence Or Death By 76% In Early-Stage, Resected, ALK+ NSCLC Adjuvant alectinib significantly improved disease-free survival in patients with ALK-positive, early-stage, non–small-cell lung cancer. Ben Solomon, MBBS, PhD, FRACP Alectinib (Alecensa), an oral ALK inhibitor, significantly improved disease-free survival (DFS) among patients with resected ALK-positive non–small-cell lung cancer (NSCLC), according to data from the phase 3 ALINA trial (NCT0345076).1 The findings, which were presented at the 2023 ESMO conference, showed that the targeted therapy elicited superior outcomes than platinum-based chemotherapy across all prespecified subgroups. Key Findings The median follow up was 27.9 months with alectinib and 27.8 months with chemotherapy. Patients with stage II-IIIA who received alectinib (n = 116) had a 76% reduced risk of disease recurrence or death...

treatment for precancerous uterine polyps :: Article Creator Endometrial (Uterine) Polyp: Watchful Waiting Vs. Removal Medically reviewed by Peter Weiss, MD Endometrial polyps are abnormal growths that form within the uterine lining. These growths are also referred to as uterine polyps. Their exact cause is unknown, but it's thought that stimulation from the hormone estrogen plays a role. Endometrial polyps are usually benign (not cancerous) and often cause no symptoms (are asymptomatic). The most common symptom they may cause is abnormal bleeding. In some instances, endometrial polyps may cause infertility. Treatment for uterine polyps includes surgical removal, but this is not always necessary. This article will discuss treatment options for endometrial polyps and explain why treatment may be needed. It will also provide information about causes and risk factors. ZeynepKaya / Getty Images Endometrial Polyp: A Mostly Benign Path...

dr frank hull pulmonologist :: Article Creator Richard C. Frank, MD Richard C. Frank, MD, is a hematologist/oncologist and director of cancer research at the Whittingham Cancer Center at Norwalk Hospital. He also serves as medical director of the Mid-Fairfield Hospice in Wilton, CT. He is the author of the book Fighting Cancer with Knowledge and Hope: A Guide for Patients, Families, and Health Care Providers, which won First Place in 2010 at the American Medical Writer's Association annual book competition. Before joining Norwalk Hospital in 2000, Frank was an attending physician at Memorial Sloan-Kettering Cancer Center in the division of hematologic oncology and was the recipient of a National Institutes of Health Physician-Scientist Grant for research studying the genetic basis of leukemia. He is a graduate of Harvard College and the State University of New York at Stony Brook School of Medicine, from which he received an MD with Distinctio...